Does Wegovy Cause Constipation? Understanding the Connection and Solutions

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active compound in medications like Wegovy, works by slowing your digestive system and signaling fullness to your brain—but this same mechanism can contribute to constipation in some patients. Clinical data shows that gastrointestinal changes occur in roughly one in four users, making constipation one of the most commonly reported side effects during the first weeks of treatment. PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A pharmacies, paired with clinical guidance to help you manage digestive adjustments effectively.

How Semaglutide Affects Your Digestive System

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone that regulates blood sugar and appetite. When semaglutide binds to GLP-1 receptors in your stomach and intestines, it slows gastric motility—the muscular contractions that move food through your digestive tract. This delayed stomach emptying is the primary reason you feel fuller longer and eat less, but it also means food travels more slowly through your colon, increasing water reabsorption and making stool harder and less frequent.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Why Some People Experience Constipation More Than Others

Not everyone on semaglutide develops constipation at the same severity or timeline. Baseline factors such as low fiber intake, chronic dehydration, sedentary lifestyle, and pre-existing digestive conditions significantly increase your risk. Additionally, genetic variations in GLP-1 receptor expression and other peptide-pathway genes can influence how intensely your gut responds to semaglutide's slowing effect. Those with slower baseline gastric emptying or lower physical activity levels tend to report more pronounced constipation during the first month.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Practical Strategies to Prevent and Manage Constipation on Semaglutide

Increasing fiber intake gradually is the first line of defense. Start by adding 5 to 10 grams of soluble fiber daily through oats, chia seeds, or psyllium-based supplements, then increase by 5 grams weekly until you reach 25 to 35 grams per day—the recommended adult intake. Fiber absorbs water and adds bulk to stool, counteracting semaglutide's dehydrating effect on your colon. Simultaneously, raise your water intake to at least 80 ounces daily, or more if you exercise regularly, because dehydration compounds constipation risk when taking GLP-1 compounds.

Physical activity is equally critical. Light walking, swimming, or gentle yoga for 20 to 30 minutes most days stimulates intestinal contractions and accelerates gastric emptying independently of medication. Timing matters too: take your semaglutide injection on the same day each week, and eat smaller, more frequent meals rather than three large ones, which reduces the overall digestive burden. If constipation persists after two weeks despite these changes, stool softeners like docusate or osmotic laxatives such as polyethylene glycol are safe to use alongside semaglutide and provide relief without interfering with weight loss.

When to Contact Your Clinician About Constipation

Mild constipation—fewer than three bowel movements per week without discomfort—is expected and usually self-limiting. However, severe abdominal pain, bloating lasting more than 48 hours, inability to have a bowel movement for over three days despite interventions, or signs of bowel obstruction require immediate medical attention. PlexusDx patients have direct access to clinical support to discuss symptom severity and adjust their management plan, including dose timing or temporary pause recommendations if constipation becomes unmanageable.

Reporting constipation to your provider is important because it provides valuable feedback about how your body is tolerating semaglutide at your current dose. Your clinician may suggest switching from injected semaglutide to oral formulation, exploring the Microdose GLP-1 Protocol ($129/mo), or considering a dual-compound approach like GLP-Squared Injection (semaglutide plus tirzepatide at $249/mo), which some patients tolerate better gastrointestinally. PlexusDx offers compounded medications from licensed 503A pharmacies across all 50 states without insurance requirements, allowing flexible adjustments to match your comfort and goals.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437 , FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is constipation from semaglutide permanent?

No. Most patients experience improvement in constipation within 4 to 8 weeks as their body adapts to semaglutide's effects. With proactive fiber, hydration, and exercise, many notice relief much sooner. If constipation persists beyond eight weeks, discuss it with your PlexusDx clinician—dose adjustment or formulation change may help.

Can I use laxatives while taking semaglutide?

Yes, over-the-counter stool softeners and osmotic laxatives are safe with semaglutide and do not interfere with weight loss. Stimulant laxatives should be used sparingly because they can cause cramping. Always inform your clinician about any laxative use so they can monitor your electrolyte balance and adjust hydration guidance as needed.

Does switching to oral semaglutide reduce constipation?

Some patients report slightly different gastrointestinal tolerability with oral semaglutide compared to injection, though both formulations work through the same mechanism. PlexusDx offers Oral Semaglutide at $289/mo month-to-month, or from $249/mo on the 6-month plan, and your clinician can help determine whether a trial of oral formulation might improve your constipation profile while maintaining weight loss benefits.

How much fiber should I add to my diet on semaglutide?

Aim for 25 to 35 grams of total fiber daily, but increase gradually by 5 grams per week to avoid gas and bloating. Soluble fiber sources like oats, ground flax, and psyllium are gentler alongside semaglutide. Pair all fiber increases with at least 80 ounces of water daily to prevent fiber from worsening constipation.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx Precision Peptide Genetic Test ($298) analyzes variants in GIPR, FTO, and MC4R genes, plus additional pathways across the panel that shape your baseline appetite-regulation and digestive biology. While constipation itself is multifactorial, understanding your genetic profile helps your clinician personalize fiber recommendations, hydration targets, and medication timing to minimize GI disruption.

Related Reading

• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy
• Hims Wegovy

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.